| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4258166 | Transplantation Proceedings | 2010 | 4 Pages |
Abstract
Concentration-controlled EVL (C0 target 3-8 ng/mL) in combination with reduced CsA exposure of one-half the usual concentration achieved good efficacy and safety over 6 months. The renal function at 6 months among the RE group showed a trend toward improvement, suggesting a benefit of halving the target CsA blood level after heart transplantation.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
S.-S. Wang, N.-K. Chou, N.-H. Chi, S.-C. Huang, I.-H. Wu, C.-H. Wang, H.-Y. Yu, Y.-S. Chen, C.-I. Tsao, W.-J. Ko, C.-T. Shun,